TrademarkOpen
Search / United States / 90790093

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

MORPHIC

Allowed — statement of use stage
Third Extension - Granted
Used for: Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic…
Show more

Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 26 Jun 2021
    Application filed
    New Application Entered
  2. 15 Mar 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 15 Mar 2022
    Office action issued
    Non-Final Action Written
  4. 15 Sep 2022
    Response to office action filed
    Teas Response To Office Action Received
  5. 30 Nov 2022
    Approved for publication
    Approved For Pub - Principal Register
  6. 3 Jan 2023
    Published for opposition
    Published For Opposition
  7. 28 Feb 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 21 Aug 2023
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 28 Feb 2024
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 30 Jul 2024
    Statement of use filed
    Teas Statement Of Use Received
  11. 27 Aug 2024
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 34 events
2026-06-03Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2026-06-03Attorney/Dom.rep.revoked And/Or Appointed
2026-06-03Teas Change Of Correspondence Received
2024-08-28Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-08-28Attorney/Dom.rep.revoked And/Or Appointed
2024-08-28Teas Change Of Correspondence Received
2024-08-28Teas Withdrawal Of Attorney Received-Firm Retains
2024-08-27Sou Teas Extension Received
2024-08-27Sou Extension 3 Filed
2024-08-27Sou Extension 3 Granted
2024-08-27Notice Of Approval Of Extension Request E-Mailed
2024-07-30Teas Statement Of Use Received
2024-02-29Notice Of Approval Of Extension Request E-Mailed
2024-02-28Sou Teas Extension Received
2024-02-28Sou Extension 2 Filed
2024-02-28Sou Extension 2 Granted
2023-08-23Notice Of Approval Of Extension Request E-Mailed
2023-08-21Sou Teas Extension Received
2023-08-21Sou Extension 1 Filed
2023-08-21Sou Extension 1 Granted
2023-02-28Noa Mailed - Sou Required From Applicant
2023-01-03Published For Opposition
2023-01-03Official Gazette Publication Confirmation E-Mailed
2022-12-14Notification Of Notice Of Publication E-Mailed
2022-11-30Approved For Pub - Principal Register
2022-09-16Teas/Email Correspondence Entered
2022-09-15Teas Response To Office Action Received
2022-09-15Correspondence Received In Law Office
2022-03-15Assigned To Examiner
2022-03-15Non-Final Action Written
2022-03-15Non-Final Action E-Mailed
2022-03-15Notification Of Non-Final Action E-Mailed
2021-09-08New Application Office Supplied Data Entered
2021-06-26New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 5 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.